The current understanding of mesenchymal stem cells as potential attenuators of chemotherapy‐induced toxicity - Rühle - 2018 - International Journal of Cancer - Wiley Online Library
Soluble Factors from Multipotent Mesenchymal Stromal Cells have Antinecrotic Effect on Cardiomyocytes in Vitro and Improve Cardiac Function in Infarcted Rat Hearts - P. Fidelis-De-Oliveira, J. P. S. Werneck-De-Castro, V. Pinho-Ribeiro, B. C. M.
PDF) Stem Cell-Based Therapy for Ischemic Heart Disease
Adult mesenchymal stem cells and women's health. - Abstract - Europe PMC
PDF) Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure
Fibrin-Enriched Cardiac Extracellular Matrix Hydrogel Promotes In Vitro Angiogenesis | ACS Biomaterials Science & Engineering
PDF) A Phase II Study of Autologous Mesenchymal Stromal Cells and c‐kit Positive Cardiac Cells, Alone or in Combination, in Patients with Ischemic Heart Failure: The CCTRN CONCERT‐HF Trial
Diabetic Mesenchymal Stem Cells Are Ineffective for Improving Limb Ischemia Due to Their Impaired Angiogenic Capability - Hyongbum Kim, Ji Woong Han, Ji Yoon Lee, Yong Jin Choi, Young-Doug Sohn, Myungjae Song,
Factors associated with implantable cardioverter defibrillators appropriate therapy in cardiac sarcoidosis: a meta-analysis
PDF) Stem and progenitor cell-based therapy in ischaemic heart disease: Promise, uncertainties, and challenges
Σαλιάρης Γεώργιος Κ. | Εμπόριο Γεωργικών Μηχανημάτων, Γεωργικά Εργαλεία & Μηχανήματα | Χίος ΧΙΟΥ , 2271023120 | vrisko.gr
A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial - Bolli - 2021 -
Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell
The current understanding of mesenchymal stem cells as potential attenuators of chemotherapy‐induced toxicity - Rühle - 2018 - International Journal of Cancer - Wiley Online Library
μηχανηματα και εξαρτηματα καμιναδας, αεραγωγων, βιομηχανικων μονωσεων
Diabetic Mesenchymal Stem Cells Are Ineffective for Improving Limb Ischemia Due to Their Impaired Angiogenic Capability - Hyongbum Kim, Ji Woong Han, Ji Yoon Lee, Yong Jin Choi, Young-Doug Sohn, Myungjae Song,
11 ΝΟΕΜΒΡΙΟΣ 2009 by pel kal - Issuu
Fibrin-Enriched Cardiac Extracellular Matrix Hydrogel Promotes In Vitro Angiogenesis | ACS Biomaterials Science & Engineering
ΣΥΝΟΠΤΙΚΟΣ Ο∆ΗΓΟΣ ΕΛΛΗΝΙΚΩΝ ΕΡΓΟΛΗΠΤΙΚΩΝ ΤΕΧΝΙΚΩΝ ΕΤΑΙΡΕΙΩΝ
ΣΥΝΟΠΤΙΚΟΣ Ο∆ΗΓΟΣ ΕΛΛΗΝΙΚΩΝ ΕΡΓΟΛΗΠΤΙΚΩΝ ΤΕΧΝΙΚΩΝ ΕΤΑΙΡΕΙΩΝ
PDF) Mesenchymal Stem Cell Insights: Prospects in Cardiovascular Therapy
PDF) Management of Chronic Congestive Heart Failure Caused by Myxomatous Mitral Valve Disease in Dogs: A Narrative Review from 1970 to 2020
Transplantation of Mesenchymal Stem Cells Exerts a Greater Long-Term Effect than Bone Marrow Mononuclear Cells in a Chronic Myocardial Infarction Model in Rat - Manuel Mazo, Juan José Gavira, Gloria Abizanda, Cristina
Calaméo - Eleftheria.gr_19/12/2009
